Boston Scientific to buy Axonics for $3.7 billion (updated)

Axonics

08/01/2024 12:21

(Adds details on deal in paragraphs 2, shares in paragraph 3)
       Jan 8 (Reuters) - Boston Scientific  BSX.N  said on
Monday it had agreed to buy medical device maker Axonics Inc
 AXNX.O  for $3.7 billion. 
   Boston Scientific will pay $71 in cash per share,
representing a 23.3% premium to the Axonics's last close.
    Shares of Axonics, which makes devices for adults with
bladder and bowel dysfunction, jumped 22% in premarket trading.
    The deal is expected to close in the first half of 2024,
after which Axonics will become a wholly owned subsidiary of
Boston Scientific.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Sriraj
Kalluvila)
 ((Sriparna.Roy@thomsonreuters.com;))